Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells

Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells

Bibliographic Details
Main Authors:	Marzec, Michal, Liu, Xiaobin, Wysocka, Maria, Rook, Alain H., Odum, Niels, Wasik, Mariusz A.
Format:	Online
Language:	English
Published:	Public Library of Science 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174990/

Similar Items

The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling
by: Delgoffe, Greg M., et al.
Published: (2011)

Combination of mTOR and EGFR Kinase Inhibitors Blocks mTORC1 and mTORC2 Kinase Activity and Suppresses the Progression of Colorectal Carcinoma
by: Wang, Quan, et al.
Published: (2013)

RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
by: Weinberg, Mark A.
Published: (2016)

Ursolic Acid Inhibits Leucine-Stimulated mTORC1 Signaling by Suppressing mTOR Localization to Lysosome
by: Ou, Xiang, et al.
Published: (2014)

Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway
by: Joubert, Pierre-Emmanuel, et al.
Published: (2015)

Glutaminolysis feeds mTORC1
by: Durán, Raúl V., et al.
Published: (2012)

Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
by: Luo, Yan, et al.
Published: (2015)

mTORC2, the “other” mTOR, is a new player in energy balance regulation
by: Cota, Daniela
Published: (2014)

Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
by: Chen, Long, et al.
Published: (2015)

AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy
by: Astle, M V, et al.
Published: (2012)

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
by: Leung, Euphemia Y., et al.
Published: (2015)

Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells
by: Eckerdt, Frank, et al.
Published: (2014)

Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model
by: Salama, Mohamed, et al.
Published: (2018)

mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation
by: Ding, Xiaolei, et al.
Published: (2016)

Regulation of TFEB and V-ATPases by mTORC1
by: Peña-Llopis, Samuel, et al.
Published: (2011)

Regulation of mTORC1 Signaling by pH
by: Balgi, Aruna D., et al.
Published: (2011)

PLD gives nutritional advice to mTORC1
by: Short, Ben
Published: (2011)

Turning acne on/off via mTORC1
by: Danby, F William
Published: (2013)

mTORC1 signaling in hepatic lipid metabolism
by: Jinbo Han, et al.
Published: (2017-04-01)

Regulation of mTORC1 by lysosomal calcium and calmodulin
by: Li, Ruo-Jing, et al.
Published: (2016)

mTORC1 sustains vision in retinitis pigmentosa
by: Petit, Lolita, et al.
Published: (2015)

Differential regulation of mTORC1 by leucine and glutamine
by: Jewell, Jenna L., et al.
Published: (2015)

An expanded role for mTORC1 in autophagy
by: Kim, Young-Mi, et al.
Published: (2015)

Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro
by: Jordan, Nicola J, et al.
Published: (2014)

Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2)
by: Barlow, A. D., et al.
Published: (2012)

mTORC2 tips the balance in cell survival
by: Sedwick, Caitlin
Published: (2015)

A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models
by: Zhang, Hao, et al.
Published: (2013)

SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt
by: Meng, Haitao, et al.
Published: (2013)

Role of AKT/mTORC1 pathway in pancreatic β-cell proliferation.
by: Balcazar Morales, Norman, et al.
Published: (2012)

Host cell mTORC1 is required for HCV RNA replication
by: Stöhr, Stefanie, et al.
Published: (2016)

Perspectives of Targeting mTORC1–S6K1 in Cardiovascular Aging
by: Ming, Xiu-Fen, et al.
Published: (2012)

mTORC1 Dependent Regulation of REDD1 Protein Stability
by: Tan, Chia Yee, et al.
Published: (2013)

Mechanism of arginine sensing by CASTOR1 upstream of mTORC1
by: Saxton, Robert A., et al.
Published: (2016)

Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2
by: Wang, Weijie, et al.
Published: (2014)

A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies
by: Mateo, Joaquin, et al.
Published: (2016)

mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system
by: Miao, Linqing, et al.
Published: (2016)

TGFβ-Induced Deptor Suppression Recruits mTORC1 and Not mTORC2 to Enhance Collagen I (α2) Gene Expression
by: Das, Falguni, et al.
Published: (2014)

mTORC2 takes the longevity stAGE
by: Lamming, Dudley W.
Published: (2014)

c-FLIP links mTORC2 to apoptosis
by: Zhao, Liqun, et al.
Published: (2014)

Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells
by: Zhang, Chao, et al.
Published: (2016)